Abstract
Neutrophils have long been considered a homogeneous cell type where all circulating cells of a particular individual express the same proteins. Lately, however, this view is changing and distinct neutrophil subsets, defined by the presence or absence of different proteins, are being increasingly recognized. At least two separate protein markers, CD177 and Olfactomedin-4 (OLFM4) are known to be expressed by some, but not all, circulating neutrophils of a given individual. We recently described the existence of subset-restricted serum autoantibodies targeting OLFM4; these were discovered during clinical testing for anti-neutrophil cytoplasmic antibodies (ANCAs). ANCA testing is part of the clinical examinations routinely carried out to support diagnosis of suspected autoimmune conditions, especially vasculitis. Positive sera typically react with all neutrophils from a single donor, whereas subset-restricted ANCA sera (such as those containing anti-OLFM4 antibodies) only react with a fraction of neutrophils. Described in this chapter is an indirect immunofluorescence (IIF) approach to test human sera for the presence of subset-restricted ANCA as well as instructions for costaining experiments using sera and purified antibodies directed against established subset markers.
Key words
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsSpringer Nature is developing a new tool to find and evaluate Protocols. Learn more
References
Weiner M, Segelmark M (2016) The clinical presentation and therapy of diseases related to anti-neutrophil cytoplasmic antibodies (ANCA). Autoimmun Rev 15(10):978–982. https://doi.org/10.1016/j.autrev.2016.07.016
Jennette JC, Falk RJ (2014) Pathogenesis of antineutrophil cytoplasmic autoantibody-mediated disease. Nat Rev Rheumatol 10(8):463–473. https://doi.org/10.1038/nrrheum.2014.103
Silvestre-Roig C, Hidalgo A, Soehnlein O (2016) Neutrophil heterogeneity: implications for homeostasis and pathogenesis. Blood 127(18):2173–2181. https://doi.org/10.1182/blood-2016-01-688887
Scapini P, Marini O, Tecchio C, Cassatella MA (2016) Human neutrophils in the saga of cellular heterogeneity: insights and open questions. Immunol Rev 273(1):48–60. https://doi.org/10.1111/imr.12448
Clemmensen SN, Bohr CT, Rorvig S, Glenthoj A, Mora-Jensen H, Cramer EP, Jacobsen LC, Larsen MT, Cowland JB, Tanassi JT, Heegaard NH, Wren JD, Silahtaroglu AN, Borregaard N (2012) Olfactomedin 4 defines a subset of human neutrophils. J Leukoc Biol 91(3):495–500. https://doi.org/10.1189/jlb.0811417
Gohring K, Wolff J, Doppl W, Schmidt KL, Fenchel K, Pralle H, Sibelius U, Bux J (2004) Neutrophil CD177 (NB1 gp, HNA-2a) expression is increased in severe bacterial infections and polycythaemia vera. Br J Haematol 126(2):252–254. https://doi.org/10.1111/j.1365-2141.2004.05027.x
Welin A, Amirbeagi F, Christenson K, Bjorkman L, Bjornsdottir H, Forsman H, Dahlgren C, Karlsson A, Bylund J (2013) The human neutrophil subsets defined by the presence or absence of OLFM4 both transmigrate into tissue in vivo and give rise to distinct NETs in vitro. PLoS One 8(7):e69575. https://doi.org/10.1371/journal.pone.0069575
Davidsson L, Bjorkman L, Christenson K, Alsterholm M, Movitz C, Thoren FB, Karlsson A, Welin A, Bylund J (2013) A simple skin blister technique for the study of in vivo transmigration of human leukocytes. J Immunol Methods 393(1–2):8–17. https://doi.org/10.1016/j.jim.2013.03.013
Amirbeagi F, Thulin P, Pullerits R, Pedersen B, Andersson BA, Dahlgren C, Welin A, Bylund J (2015) Olfactomedin-4 autoantibodies give unusual c-ANCA staining patterns with reactivity to a subpopulation of neutrophils. J Leukoc Biol 97(1):181–189. https://doi.org/10.1189/jlb.5A0614-311R
Goldschmeding R, van Dalen CM, Faber N, Calafat J, Huizinga TW, van der Schoot CE, Clement LT, von dem Borne AE (1992) Further characterization of the NB 1 antigen as a variably expressed 56-62 kD GPI-linked glycoprotein of plasma membranes and specific granules of neutrophils. Br J Haematol 81(3):336–345
Lalezari P, Murphy GB, Allen FH Jr (1971) NB1, a new neutrophil-specific antigen involved in the pathogenesis of neonatal neutropenia. J Clin Invest 50(5):1108–1115. https://doi.org/10.1172/JCI106582
Malki A, Fiedler J, Fricke K, Ballweg I, Pfaffl MW, Krautwurst D (2015) Class I odorant receptors, TAS1R and TAS2R taste receptors, are markers for subpopulations of circulating leukocytes. J Leukoc Biol 97(3):533–545. https://doi.org/10.1189/jlb.2A0714-331RR
Boyum A (1968) Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g. Scand J Clin Lab Invest Suppl 97:77–89
Boyum A, Lovhaug D, Tresland L, Nordlie EM (1991) Separation of leucocytes: improved cell purity by fine adjustments of gradient medium density and osmolality. Scand J Immunol 34(6):697–712
Weil GJ, Chused TM (1981) Eosinophil autofluorescence and its use in isolation and analysis of human eosinophils using flow microfluorometry. Blood 57(6):1099–1104
Matsuo K, Lin A, Procter JL, Clement L, Stroncek D (2000) Variations in the expression of granulocyte antigen NB1. Transfusion 40(6):654–662
Dolman KM, Damsma I, Tool AT, Sonnenberg A, von dem Borne AE, Goldschmeding R (1993) A novel specificity of anticytoplasmic autoantibodies directed against eosinophil peroxidase. Clin Exp Immunol 92(1):58–64
Beauvillain C, Delneste Y, Renier G, Jeannin P, Subra JF, Chevailler A (2008) Antineutrophil cytoplasmic autoantibodies: how should the biologist manage them? Clin Rev Allergy Immunol 35(1–2):47–58. https://doi.org/10.1007/s12016-007-8071-9
Savige JA, Paspaliaris B, Silvestrini R, Davies D, Nikoloutsopoulos T, Sturgess A, Neil J, Pollock W, Dunster K, Hendle M (1998) A review of immunofluorescent patterns associated with antineutrophil cytoplasmic antibodies (ANCA) and their differentiation from other antibodies. J Clin Pathol 51(8):568–575
Saxon A, Shanahan F, Landers C, Ganz T, Targan S (1990) A distinct subset of antineutrophil cytoplasmic antibodies is associated with inflammatory bowel disease. J Allergy Clin Immunol 86(2):202–210
Savige JA, Gallicchio MC, Stockman A, Cunningham TJ, Rowley MJ, Georgiou T, Davies D (1991) Anti-neutrophil cytoplasm antibodies in rheumatoid arthritis. Clin Exp Immunol 86(1):92–98
Zhao MH, Jones SJ, Lockwood CM (1995) Bactericidal/permeability-increasing protein (BPI) is an important antigen for anti-neutrophil cytoplasmic autoantibodies (ANCA) in vasculitis. Clin Exp Immunol 99(1):49–56
Stroncek DF, Egging MS, Eiber GA, Clay ME (1993) Neutrophil alloantibodies react with cytoplasmic antigens: a possible cause of false-positive indirect immunofluorescence assays for antibodies to neutrophil cytoplasmic antigens. Am J Kidney Dis 21(4):368–373
Acknowledgments
This work was supported by grants from the Swedish Research Council (2016-00982 and 2014-00396), the Swedish Heart and Lung Foundation, The King Gustaf the Vth 80-year foundation, and the Swedish state through the ALF and TUA agreements.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Amirbeagi, F., Welin, A., Thulin, P., Bylund, J. (2019). Determination of Subset-Restricted Anti-neutrophil Cytoplasmic Antibodies (ANCA) by Immunofluorescence Cytochemistry. In: Houen, G. (eds) Autoantibodies. Methods in Molecular Biology, vol 1901. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-8949-2_5
Download citation
DOI: https://doi.org/10.1007/978-1-4939-8949-2_5
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-8948-5
Online ISBN: 978-1-4939-8949-2
eBook Packages: Springer Protocols